The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
351
Episode 48: The AI hype machine, ketamine's fut...
When will AI replace your radiologist? What can p…
23 min
352
Episode 47: A bad day for bold biotech, campaig...
Are we underestimating biology? Will Hot 97 decid…
26 min
353
Episode 46: Another Alzheimer's setback, crypto...
Is the drug industry wrong about Alzheimer's dise…
24 min
354
Episode 45: CRISPR upheaval, Celgene's chutzpah...
Is genome editing harder than anyone thought? Wil…
24 min
355
Episode 44: FDA furloughs, '80s pop radio, and ...
Is the FDA going broke? Can video games be drugs?…
23 min
356
Episode 43: A people's history of J.P. Morgan
Do drug developers tip well? Is biotech safe for …
14 min
357
Episode 42: Parsing Bristol-Myers-Celgene, grou...
Are megamergers bad for business? Is it time for …
22 min
358
Episode 41: Watson's latest stumble, a glimpse ...
What will become of biotech in 2019? What's the l…
26 min
359
Episode 40: Gilead’s new boss, the year that wa...
Is Gilead Sciences entering a bold new era? What …
23 min
360
Episode 39: Using the word 'cure,' an FDA looph...
Can gene therapy cure sickle cell disease? Is an …
22 min
361
Episode 38: Your guide to the #CRISPRbabies con...
What does it mean to edit a person? Has science r…
23 min
362
Episode 37: The biggest-ever IPO, drug prices r...
Can unicorns float? Is a hot dog a sandwich? And …
26 min
363
Episode 36: What the midterms mean, a golden ag...
Is pharma in for a swarm of subpoenas? Are we run…
22 min
364
Episode 35: Biotech's October slump, the precis...
Why are biotech stocks in the dumps? Is the lates…
26 min
365
Episode 34: Pharma at the ballot box, the lates...
Can pharma-shaming get someone re-elected? How ra…
21 min
366
Episode 33: Drug prices on TV, immortal blockbu...
Are prescription drugs like new cars? Is pharma's…
24 min
367
Episode 32: Fake friends at the FDA, cancer cou...
Is the next big idea in oncology a bust? What doe…
22 min
368
Episode 31: Nobel snubs, millenial founders, an...
Did the Nobel Prizes go to the right scientists? …
23 min
369
Episode 30: A fish oil epiphany, VC monopolies ...
Was everyone wrong about fish oil? Is venture cap…
25 min
370
Episode 29: A Hong Kong heat-check, a $20 milli...
Is a biotech bubble inflating in China? Do the fe…
24 min
371
Episode 28: Founders' funds, doctors' disclosur...
Is biotech too founder-friendly? Is honesty overr…
22 min
372
Episode 27: Live from Boston!
Should genome editors be worried? Has 2018 been a…
26 min
373
Episode 26: FDA shows its teeth, biotech fish ...
Is the FDA as lenient as everyone thinks? Can fis…
17 min
374
Episode 25: A genome-editing first, Trump on Wa...
Can genome-editing work in actual people? Are CEO…
21 min
375
Episode 24: A lesson in startup jargon, pharma'...
How much is a shot at curing cancer worth? Where …
23 min